The upregulation or overexpression of SMG-1 potentially suppresses tumor growth and metastasis, whereas SMG-1 downregulation promotes tumor progression in gastric cancer and hepatocellular carcinoma [1 ,3,4]. The gene discussed is SMG1; the disease is gastric cancer.